Summary
Wilson’s disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson’s disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson’s disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson’s disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
According to APO Research, The global Wilson's Disease market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Wilson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Wilson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Wilson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Wilson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Wilson's Disease include Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, ANI Pharmaceuticals, APOTEX, Tsumura and Sinepharm, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Wilson's Disease, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Wilson's Disease, also provides the revenue of main regions and countries. Of the upcoming market potential for Wilson's Disease, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Wilson's Disease revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Wilson's Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Wilson's Disease revenue, projected growth trends, production technology, application and end-user industry.
Wilson's Disease segment by Company
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings
Wilson's Disease segment by Type
Trientine
Penicillamine
Others
Wilson's Disease segment by Application
Hospital
Drugs Stores
Others
Wilson's Disease segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Wilson's Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Wilson's Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Wilson's Disease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Wilson's Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Wilson's Disease company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Wilson's Disease revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Wilson's Disease Market by Type
1.2.1 Global Wilson's Disease Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Trientine
1.2.3 Penicillamine
1.2.4 Others
1.3 Wilson's Disease Market by Application
1.3.1 Global Wilson's Disease Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Wilson's Disease Market Dynamics
2.1 Wilson's Disease Industry Trends
2.2 Wilson's Disease Industry Drivers
2.3 Wilson's Disease Industry Opportunities and Challenges
2.4 Wilson's Disease Industry Restraints
3 Global Growth Perspective
3.1 Global Wilson's Disease Market Perspective (2019-2030)
3.2 Global Wilson's Disease Growth Trends by Region
3.2.1 Global Wilson's Disease Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Wilson's Disease Market Size by Region (2019-2024)
3.2.3 Global Wilson's Disease Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Wilson's Disease Revenue by Players
4.1.1 Global Wilson's Disease Revenue by Players (2019-2024)
4.1.2 Global Wilson's Disease Revenue Market Share by Players (2019-2024)
4.1.3 Global Wilson's Disease Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Wilson's Disease Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Wilson's Disease Key Players Headquarters & Area Served
4.4 Global Wilson's Disease Players, Product Type & Application
4.5 Global Wilson's Disease Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Wilson's Disease Market CR5 and HHI
4.6.2 Global Top 5 and 10 Wilson's Disease Players Market Share by Revenue in 2023
4.6.3 2023 Wilson's Disease Tier 1, Tier 2, and Tier 3
5 Wilson's Disease Market Size by Type
5.1 Global Wilson's Disease Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Wilson's Disease Revenue by Type (2019-2030)
5.3 Global Wilson's Disease Revenue Market Share by Type (2019-2030)
6 Wilson's Disease Market Size by Application
6.1 Global Wilson's Disease Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Wilson's Disease Revenue by Application (2019-2030)
6.3 Global Wilson's Disease Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Bausch Health
7.1.1 Bausch Health Comapny Information
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Wilson's Disease Revenue and Gross Margin (2019-2024)
7.1.4 Bausch Health Wilson's Disease Product Portfolio
7.1.5 Bausch Health Recent Developments
7.2 Teva
7.2.1 Teva Comapny Information
7.2.2 Teva Business Overview
7.2.3 Teva Wilson's Disease Revenue and Gross Margin (2019-2024)
7.2.4 Teva Wilson's Disease Product Portfolio
7.2.5 Teva Recent Developments
7.3 Endo International
7.3.1 Endo International Comapny Information
7.3.2 Endo International Business Overview
7.3.3 Endo International Wilson's Disease Revenue and Gross Margin (2019-2024)
7.3.4 Endo International Wilson's Disease Product Portfolio
7.3.5 Endo International Recent Developments
7.4 Univar Solutions
7.4.1 Univar Solutions Comapny Information
7.4.2 Univar Solutions Business Overview
7.4.3 Univar Solutions Wilson's Disease Revenue and Gross Margin (2019-2024)
7.4.4 Univar Solutions Wilson's Disease Product Portfolio
7.4.5 Univar Solutions Recent Developments
7.5 MSN Laboratories
7.5.1 MSN Laboratories Comapny Information
7.5.2 MSN Laboratories Business Overview
7.5.3 MSN Laboratories Wilson's Disease Revenue and Gross Margin (2019-2024)
7.5.4 MSN Laboratories Wilson's Disease Product Portfolio
7.5.5 MSN Laboratories Recent Developments
7.6 ANI Pharmaceuticals
7.6.1 ANI Pharmaceuticals Comapny Information
7.6.2 ANI Pharmaceuticals Business Overview
7.6.3 ANI Pharmaceuticals Wilson's Disease Revenue and Gross Margin (2019-2024)
7.6.4 ANI Pharmaceuticals Wilson's Disease Product Portfolio
7.6.5 ANI Pharmaceuticals Recent Developments
7.7 APOTEX
7.7.1 APOTEX Comapny Information
7.7.2 APOTEX Business Overview
7.7.3 APOTEX Wilson's Disease Revenue and Gross Margin (2019-2024)
7.7.4 APOTEX Wilson's Disease Product Portfolio
7.7.5 APOTEX Recent Developments
7.8 Tsumura
7.8.1 Tsumura Comapny Information
7.8.2 Tsumura Business Overview
7.8.3 Tsumura Wilson's Disease Revenue and Gross Margin (2019-2024)
7.8.4 Tsumura Wilson's Disease Product Portfolio
7.8.5 Tsumura Recent Developments
7.9 Sinepharm
7.9.1 Sinepharm Comapny Information
7.9.2 Sinepharm Business Overview
7.9.3 Sinepharm Wilson's Disease Revenue and Gross Margin (2019-2024)
7.9.4 Sinepharm Wilson's Disease Product Portfolio
7.9.5 Sinepharm Recent Developments
7.10 Taj Pharmaceutical
7.10.1 Taj Pharmaceutical Comapny Information
7.10.2 Taj Pharmaceutical Business Overview
7.10.3 Taj Pharmaceutical Wilson's Disease Revenue and Gross Margin (2019-2024)
7.10.4 Taj Pharmaceutical Wilson's Disease Product Portfolio
7.10.5 Taj Pharmaceutical Recent Developments
7.11 Kadmon Holdings
7.11.1 Kadmon Holdings Comapny Information
7.11.2 Kadmon Holdings Business Overview
7.11.3 Kadmon Holdings Wilson's Disease Revenue and Gross Margin (2019-2024)
7.11.4 Kadmon Holdings Wilson's Disease Product Portfolio
7.11.5 Kadmon Holdings Recent Developments
8 North America
8.1 North America Wilson's Disease Revenue (2019-2030)
8.2 North America Wilson's Disease Revenue by Type (2019-2030)
8.2.1 North America Wilson's Disease Revenue by Type (2019-2024)
8.2.2 North America Wilson's Disease Revenue by Type (2025-2030)
8.3 North America Wilson's Disease Revenue Share by Type (2019-2030)
8.4 North America Wilson's Disease Revenue by Application (2019-2030)
8.4.1 North America Wilson's Disease Revenue by Application (2019-2024)
8.4.2 North America Wilson's Disease Revenue by Application (2025-2030)
8.5 North America Wilson's Disease Revenue Share by Application (2019-2030)
8.6 North America Wilson's Disease Revenue by Country
8.6.1 North America Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Wilson's Disease Revenue by Country (2019-2024)
8.6.3 North America Wilson's Disease Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Wilson's Disease Revenue (2019-2030)
9.2 Europe Wilson's Disease Revenue by Type (2019-2030)
9.2.1 Europe Wilson's Disease Revenue by Type (2019-2024)
9.2.2 Europe Wilson's Disease Revenue by Type (2025-2030)
9.3 Europe Wilson's Disease Revenue Share by Type (2019-2030)
9.4 Europe Wilson's Disease Revenue by Application (2019-2030)
9.4.1 Europe Wilson's Disease Revenue by Application (2019-2024)
9.4.2 Europe Wilson's Disease Revenue by Application (2025-2030)
9.5 Europe Wilson's Disease Revenue Share by Application (2019-2030)
9.6 Europe Wilson's Disease Revenue by Country
9.6.1 Europe Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Wilson's Disease Revenue by Country (2019-2024)
9.6.3 Europe Wilson's Disease Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Wilson's Disease Revenue (2019-2030)
10.2 China Wilson's Disease Revenue by Type (2019-2030)
10.2.1 China Wilson's Disease Revenue by Type (2019-2024)
10.2.2 China Wilson's Disease Revenue by Type (2025-2030)
10.3 China Wilson's Disease Revenue Share by Type (2019-2030)
10.4 China Wilson's Disease Revenue by Application (2019-2030)
10.4.1 China Wilson's Disease Revenue by Application (2019-2024)
10.4.2 China Wilson's Disease Revenue by Application (2025-2030)
10.5 China Wilson's Disease Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Wilson's Disease Revenue (2019-2030)
11.2 Asia Wilson's Disease Revenue by Type (2019-2030)
11.2.1 Asia Wilson's Disease Revenue by Type (2019-2024)
11.2.2 Asia Wilson's Disease Revenue by Type (2025-2030)
11.3 Asia Wilson's Disease Revenue Share by Type (2019-2030)
11.4 Asia Wilson's Disease Revenue by Application (2019-2030)
11.4.1 Asia Wilson's Disease Revenue by Application (2019-2024)
11.4.2 Asia Wilson's Disease Revenue by Application (2025-2030)
11.5 Asia Wilson's Disease Revenue Share by Application (2019-2030)
11.6 Asia Wilson's Disease Revenue by Country
11.6.1 Asia Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Wilson's Disease Revenue by Country (2019-2024)
11.6.3 Asia Wilson's Disease Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Wilson's Disease Revenue (2019-2030)
12.2 MEALA Wilson's Disease Revenue by Type (2019-2030)
12.2.1 MEALA Wilson's Disease Revenue by Type (2019-2024)
12.2.2 MEALA Wilson's Disease Revenue by Type (2025-2030)
12.3 MEALA Wilson's Disease Revenue Share by Type (2019-2030)
12.4 MEALA Wilson's Disease Revenue by Application (2019-2030)
12.4.1 MEALA Wilson's Disease Revenue by Application (2019-2024)
12.4.2 MEALA Wilson's Disease Revenue by Application (2025-2030)
12.5 MEALA Wilson's Disease Revenue Share by Application (2019-2030)
12.6 MEALA Wilson's Disease Revenue by Country
12.6.1 MEALA Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Wilson's Disease Revenue by Country (2019-2024)
12.6.3 MEALA Wilson's Disease Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Wilson's Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Trientine Major Manufacturers
Table 2. Penicillamine Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Wilson's Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Hospital Major Manufacturers
Table 6. Drugs Stores Major Manufacturers
Table 7. Others Major Manufacturers
Table 8. Wilson's Disease Industry Trends
Table 9. Wilson's Disease Industry Drivers
Table 10. Wilson's Disease Industry Opportunities and Challenges
Table 11. Wilson's Disease Industry Restraints
Table 12. Global Wilson's Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Wilson's Disease Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Wilson's Disease Market Share by Region (2019-2024)
Table 15. Global Wilson's Disease Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Wilson's Disease Market Share by Region (2025-2030)
Table 17. Global Wilson's Disease Revenue by Players (US$ Million) & (2019-2024)
Table 18. Global Wilson's Disease Revenue Market Share by Players (2019-2024)
Table 19. Global Wilson's Disease Key Players Ranking, 2022 VS 2023 VS 2024
Table 20. Global Wilson's Disease Key Players Headquarters & Area Served
Table 21. Global Wilson's Disease Players, Product Type & Application
Table 22. Global Wilson's Disease Players Commercialization Time
Table 23. Global Players Market Concentration Ratio (CR5 and HHI)
Table 24. Global Wilson's Disease by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 25. Global Wilson's Disease Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Wilson's Disease Revenue by Type (2019-2024) & (US$ Million)
Table 27. Global Wilson's Disease Revenue by Type (2025-2030) & (US$ Million)
Table 28. Global Wilson's Disease Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 29. Global Wilson's Disease Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 30. Global Wilson's Disease Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Global Wilson's Disease Revenue by Application (2019-2024) & (US$ Million)
Table 32. Global Wilson's Disease Revenue by Application (2025-2030) & (US$ Million)
Table 33. Global Wilson's Disease Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 34. Global Wilson's Disease Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 35. Bausch Health Company Information
Table 36. Bausch Health Business Overview
Table 37. Bausch Health Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. Bausch Health Wilson's Disease Product Portfolio
Table 39. Bausch Health Recent Development
Table 40. Teva Company Information
Table 41. Teva Business Overview
Table 42. Teva Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Teva Wilson's Disease Product Portfolio
Table 44. Teva Recent Development
Table 45. Endo International Company Information
Table 46. Endo International Business Overview
Table 47. Endo International Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. Endo International Wilson's Disease Product Portfolio
Table 49. Endo International Recent Development
Table 50. Univar Solutions Company Information
Table 51. Univar Solutions Business Overview
Table 52. Univar Solutions Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. Univar Solutions Wilson's Disease Product Portfolio
Table 54. Univar Solutions Recent Development
Table 55. MSN Laboratories Company Information
Table 56. MSN Laboratories Business Overview
Table 57. MSN Laboratories Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. MSN Laboratories Wilson's Disease Product Portfolio
Table 59. MSN Laboratories Recent Development
Table 60. ANI Pharmaceuticals Company Information
Table 61. ANI Pharmaceuticals Business Overview
Table 62. ANI Pharmaceuticals Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. ANI Pharmaceuticals Wilson's Disease Product Portfolio
Table 64. ANI Pharmaceuticals Recent Development
Table 65. APOTEX Company Information
Table 66. APOTEX Business Overview
Table 67. APOTEX Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. APOTEX Wilson's Disease Product Portfolio
Table 69. APOTEX Recent Development
Table 70. Tsumura Company Information
Table 71. Tsumura Business Overview
Table 72. Tsumura Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Tsumura Wilson's Disease Product Portfolio
Table 74. Tsumura Recent Development
Table 75. Sinepharm Company Information
Table 76. Sinepharm Business Overview
Table 77. Sinepharm Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Sinepharm Wilson's Disease Product Portfolio
Table 79. Sinepharm Recent Development
Table 80. Taj Pharmaceutical Company Information
Table 81. Taj Pharmaceutical Business Overview
Table 82. Taj Pharmaceutical Wilson's Disease Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 83. Taj Pharmaceutical Wilson's Disease Product Portfolio
Table 84. Taj Pharmaceutical Recent Development
Table 85. Kadmon Holdings Company Information
Table 86. Kadmon Holdings Business Overview
Table 87. Kadmon Holdings Wilson's Disease Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
Table 88. Kadmon Holdings Wilson's Disease Product Portfolio
Table 89. Kadmon Holdings Recent Development
Table 90. North America Wilson's Disease Revenue by Type (2019-2024) & (US$ Million)
Table 91. North America Wilson's Disease Revenue by Application (2019-2024) & (US$ Million)
Table 92. North America Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 93. North America Wilson's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 94. North America Wilson's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 95. Europe Wilson's Disease Revenue by Type (2019-2024) & (US$ Million)
Table 96. Europe Wilson's Disease Revenue by Application (2019-2024) & (US$ Million)
Table 97. Europe Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 98. Europe Wilson's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 99. Europe Wilson's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 100. China Wilson's Disease Revenue by Type (2019-2024) & (US$ Million)
Table 101. China Wilson's Disease Revenue by Application (2019-2024) & (US$ Million)
Table 102. Asia Wilson's Disease Revenue by Type (2019-2024) & (US$ Million)
Table 103. Asia Wilson's Disease Revenue by Application (2019-2024) & (US$ Million)
Table 104. Asia Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 105. Asia Wilson's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 106. Asia Wilson's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 107. MEALA Wilson's Disease Revenue by Type (2019-2024) & (US$ Million)
Table 108. MEALA Wilson's Disease Revenue by Application (2019-2024) & (US$ Million)
Table 109. MEALA Wilson's Disease Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 110. MEALA Wilson's Disease Revenue by Country (2019-2024) & (US$ Million)
Table 111. MEALA Wilson's Disease Revenue by Country (2025-2030) & (US$ Million)
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources
List of Figures
Figure 1. Wilson's Disease Product Picture
Figure 2. Global Wilson's Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Wilson's Disease Market Size Share 2019 VS 2023 VS 2030
Figure 4. Trientine Picture
Figure 5. Penicillamine Picture
Figure 6. Others Picture
Figure 7. Global Wilson's Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Wilson's Disease Market Size Share 2019 VS 2023 VS 2030
Figure 9. Hospital Picture
Figure 10. Drugs Stores Picture
Figure 11. Others Picture
Figure 12. Global Wilson's Disease Market Size (US$ Million) & (2019-2030)
Figure 13. Global Wilson's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Wilson's Disease Market Share by Region: 2019 VS 2023 VS 2030
Figure 15. Global Wilson's Disease Players Revenue Share Top 10 and Top 5 in 2023
Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 17. Global Wilson's Disease Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Wilson's Disease Revenue Market Share 2019 VS 2023 VS 2030
Figure 19. Global Wilson's Disease Revenue Market Share by Type (2019-2030)
Figure 20. Global Wilson's Disease Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Wilson's Disease Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 22. Global Wilson's Disease Revenue Market Share by Application (2019-2030)
Figure 23. North America Wilson's Disease Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Wilson's Disease Revenue by Type (2025-2030) & (US$ Million)
Figure 25. North America Wilson's Disease Revenue Share by Type (2019-2030)
Figure 26. North America Wilson's Disease Revenue by Application (2025-2030) & (US$ Million)
Figure 27. North America Wilson's Disease Revenue Share by Application (2019-2030)
Figure 28. North America Wilson's Disease Revenue Share by Country (2019-2030)
Figure 29. United States Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Canada Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Europe Wilson's Disease Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 32. Europe Wilson's Disease Revenue by Type (2025-2030) & (US$ Million)
Figure 33. Europe Wilson's Disease Revenue Share by Type (2019-2030)
Figure 34. Europe Wilson's Disease Revenue by Application (2025-2030) & (US$ Million)
Figure 35. Europe Wilson's Disease Revenue Share by Application (2019-2030)
Figure 36. Europe Wilson's Disease Revenue Share by Country (2019-2030)
Figure 37. Germany Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. France Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. U.K. Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Italy Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Russia Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Nordic Countries Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. China Wilson's Disease Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Wilson's Disease Revenue by Type (2025-2030) & (US$ Million)
Figure 45. China Wilson's Disease Revenue Share by Type (2019-2030)
Figure 46. China Wilson's Disease Revenue by Application (2025-2030) & (US$ Million)
Figure 47. China Wilson's Disease Revenue Share by Application (2019-2030)
Figure 48. Asia Wilson's Disease Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 49. Asia Wilson's Disease Revenue by Type (2025-2030) & (US$ Million)
Figure 50. Asia Wilson's Disease Revenue Share by Type (2019-2030)
Figure 51. Asia Wilson's Disease Revenue by Application (2025-2030) & (US$ Million)
Figure 52. Asia Wilson's Disease Revenue Share by Application (2019-2030)
Figure 53. Asia Wilson's Disease Revenue Share by Country (2019-2030)
Figure 54. Japan Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. South Korea Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. India Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. Australia Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. China Taiwan Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. Southeast Asia Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. MEALA Wilson's Disease Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 61. MEALA Wilson's Disease Revenue by Type (2025-2030) & (US$ Million)
Figure 62. MEALA Wilson's Disease Revenue Share by Type (2019-2030)
Figure 63. MEALA Wilson's Disease Revenue by Application (2025-2030) & (US$ Million)
Figure 64. MEALA Wilson's Disease Revenue Share by Application (2019-2030)
Figure 65. MEALA Wilson's Disease Revenue Share by Country (2019-2030)
Figure 66. Mexico Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. South Korea Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Brazil Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Israel Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Argentina Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Colombia Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Turkey Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Saudi Arabia Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. UAE Wilson's Disease Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
